Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discoveryERLANSON, Daniel A; ARNDT, Joseph W; KUMARAVEL, Gnanasambandam et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 10, pp 3078-3083, issn 0960-894X, 6 p.Article

Structural basis of cell surface receptor recognition by botulinum neurotoxin BQING CHAI; ARNDT, Joseph W; MIN DONG et al.Nature (London). 2006, Vol 444, Num 7122, pp 1096-1100, issn 0028-0836, 5 p.Article

Heat Shock Protein 90: Inhibitors in Clinical TrialsBIAMONTE, Marco A; VAN DE WATER, Ryan; ARNDT, Joseph W et al.Journal of medicinal chemistry (Print). 2010, Vol 53, Num 1, pp 3-17, issn 0022-2623, 15 p.Article

Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxinGARCIA-RODRIGUEZ, Consuelo; LEVY, Raphael; ARNDT, Joseph W et al.Nature biotechnology (Print). 2007, Vol 25, Num 1, pp 107-116, issn 1087-0156, 10 p.Article